Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Compend Contin Educ Dent ; 42(3): 140-141, 2021 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-34010575

RESUMO

Advancements in digital dentistry technology continue to change how dentists work. The recent onset of COVID-19 has presented new challenges to dentists by prompting renewed priorities such as providing patients with peace of mind, controlling and reducing contamination risks, and increasing treatment efficiency to boost productivity and profitability. Digital technologies such as intraoral scanners and in-office CAD/CAM systems are, in many ways, the ideal tools to use in meeting these new challenges, and thus dentists are turning to digital methods faster than ever before.


Assuntos
COVID-19 , Desenho Assistido por Computador , Humanos , SARS-CoV-2
2.
Cell Stem Cell ; 27(6): 869-875.e4, 2020 12 03.
Artigo em Inglês | MEDLINE | ID: mdl-33259798

RESUMO

Current smoking is associated with increased risk of severe COVID-19, but it is not clear how cigarette smoke (CS) exposure affects SARS-CoV-2 airway cell infection. We directly exposed air-liquid interface (ALI) cultures derived from primary human nonsmoker airway basal stem cells (ABSCs) to short term CS and then infected them with SARS-CoV-2. We found an increase in the number of infected airway cells after CS exposure with a lack of ABSC proliferation. Single-cell profiling of the cultures showed that the normal interferon response was reduced after CS exposure with infection. Treatment of CS-exposed ALI cultures with interferon ß-1 abrogated the viral infection, suggesting one potential mechanism for more severe viral infection. Our data show that acute CS exposure allows for more severe airway epithelial disease from SARS-CoV-2 by reducing the innate immune response and ABSC proliferation and has implications for disease spread and severity in people exposed to CS.


Assuntos
COVID-19/fisiopatologia , Mucosa Respiratória/fisiopatologia , Fumar/efeitos adversos , Células-Tronco/virologia , COVID-19/genética , COVID-19/imunologia , COVID-19/terapia , Células Cultivadas , Regulação para Baixo , Humanos , Imunidade Inata , Interferon beta/uso terapêutico , Gravidade do Paciente , Mucosa Respiratória/virologia
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa